VMD · CIK 0001729149
What Viemed Healthcare, Inc. told the SEC could break it.
Viemed's revenue runs almost entirely through third-party payors: about 40% came from Medicare and Medicaid in 2025 (Medicare its primary payor) and roughly 50% from managed-care and commercial insurers, so payment slowdowns or reimbursement cuts would hit it materially. Its single largest line, ventilators (about 51% of revenue), is exposed to a specific regulatory lever — a CMS National Coverage Determination setting medical-necessity criteria, which could reshape patient access, utilization and reimbursement, including across Medicare Advantage and commercial plans that align with CMS rules. And although nearly all its revenue is U.S.-based, it rents and sells equipment sourced from both domestic and international suppliers, leaving it exposed to tariffs and supply-chain disruption.
3 self-disclosed vulnerabilities, pulled from its own filings, each in the company’s words, with the source. This is the risk register almost nobody reads.
In its own words
What could break it.
Customer concentration
- third-party payor concentration (Medicare/Medicaid ~40%, primary payor Medicare)high
Viemed depends heavily on third-party payors — ~40% of 2025 revenue from Medicare/Medicaid (Medicare its primary payor) and ~50% from managed care/commercial insurers — so payment slowdowns or reimbursement cuts would materially impact it.
“In 2025, approximately 50% of our revenue was associated with managed care plans, commercial health insurers, workers' compensation payors, and other third-party payor arrangements while approximately 40% of our revenues were derived from Medicare and Medicaid.”
SEC filing →As of 2026
Regulatory & policy
- CMS National Coverage Determination on ventilator medical-necessity criteriamedium
A CMS NCD setting medical-necessity criteria for ventilators (Viemed's largest revenue line at ~51%) could change patient access, utilization and reimbursement — including via Medicare Advantage and commercial plans that align with CMS criteria.
“In addition to affecting traditional Medicare, the NCD may also influence coverage determinations and reimbursement policies under commercial insurance and Medicare Advantage plans that reference or align with CMS coverage criteria. These changes may have a material impact on our business.”
SEC filing →As of 2026
Supplier concentration
- reliance on domestic/international suppliers for rented medical equipment (tariff/supply-chain exposure)medium
Viemed rents and sells medical equipment and supplies sourced from both domestic and international suppliers, exposing it to tariffs, supply-chain disruption and FX even though nearly all revenue is U.S.-based.
“While nearly all of our revenues are generated within the United States and denominated in U.S. dollars, we rely on both domestic and international suppliers for the medical equipment and supplies we rent”
SEC filing →As of 2026
In the MyPRIA app, this is checked against the companies you actually own.
← World Watch